Trial intelligence / Profile preview

Diazepam added to tolterodine for bladder spasm pain after open prostatectomy

IRCT20190127042515N1Phase 3Completed

Sponsor
Bushehr University of Medical Sciences
Start
Feb 2019
Modality
Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3, open-label trial of diazepam, tolterodine and methadone in cystospasm (2 arms), sponsored by Bushehr University of Medical Sciences. Primary endpoints: Bladder spasm pain severity, Rescue methadone use and 3 more. Started Feb 2019; status: completed.

02

Drugs

diazepamtolterodinemethadone
03

Conditions

cystospasm

Beyond the preview

Go deeper on IRCT20190127042515N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20190127042515N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call